PajekJ., KvederR., BrenA., GucekA., IhanA., OsredkarJ.Short-term effects of a new bicarbonate/lactate-buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study.Perit Dial Int2008; 28: 44–52.
2.
RougierJ.P., MoullierP., PiedagnelR., RoncoP.M.Hyperosmolality suppresses but TGF beta 1 increases MMP9 in human peritoneal mesothelial cells.Kidney Int1997; 51: 337–47.
3.
WitowskiJ., BenderT., Wisniewska-ElnurJ., KsiazekK., Passlick-DeetjenJ., BreborowiczA.Mesothelial toxicity of peritoneal dialysis fluids is related primarily to glucose degradation products, not to glucose per se.Perit Dial Int2003; 23: 381–90.
4.
MiyataT., UedaY., YamadaY., IzuharaY., WadaT., JadoulM.Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia.J Am Soc Nephrol1998; 9: 2349–56.
5.
TopleyN., KaurD., PetersenM.M., JorresA., WilliamsJ.D., FaictD.In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function.J Am Soc Nephrol1996; 7: 218–24.
6.
SchmidtA.M., ViannaM., GerlachM., BrettJ., RyanJ., KaoJ.Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface.J Biol Chem1992; 267: 14987–97.
7.
SchmidtA.M., YanS.D., YanS.F., SternD.M.The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses.J Clin Invest2001; 108: 949–55.
8.
BoulangerE., WautierM.P., GaneP., MarietteC., DevuystO., WautierJ.L.The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products.Nephrol Dial Transplant2004; 19: 2208–16.
9.
BoulangerE., GrossinN., WautierM.P., TaammaR., WautierJ.L.Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation.Kidney Int2007; 71: 126–33.
10.
BoulangerE., WautierM.P., WautierJ.L., BovalB., PanisY., WernertN.AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression.Kidney Int2002; 61: 148–56.
11.
MortierS., FaictD., LameireN., De VrieseA.Benefits of switching from a conventional to a low-GDP bicarbonate/ lactate-buffered dialysis solution in a rat model.Kidney Int2005; 67: 1559–65.
12.
De VrieseA.S., FlyvbjergA., MortierS., TiltonR.G., LameireN.H.Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane.J Am Soc Nephrol2003; 14: 2109–18.
13.
JonassonP., BraideM.Acute in vivo toxicity of heat-sterilized glucose peritoneal dialysis fluids to rat peritoneal macrophages.Perit Dial Int1998; 18: 376–81.
14.
SzetoC., ChowK., LamC., LeungC., KwanB., ChungK.Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products—a 1-year randomized control trial.Nephrol Dial Transplant2007; 22: 552–9.
15.
FoleyR., MurrayA., LiS., HerzogC., McBeanA., EggersP.Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999.J Am Soc Nephrol2005; 16: 489–95.
16.
Pecoits-FilhoR., LindholmB., StenvinkelP.End-stage renal disease: a state of chronic inflammation and hyperleptinemia.Eur J Clin Invest2003; 33: 527–8.
VlassaraH., StrikerL.J., TeichbergS., FuhH., LiY.M., SteffesM.Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats.Proc Natl Acad Sci U S A1994; 91: 11704–8.
19.
WautierJ.L., WautierM.P., SchmidtA.M., AndersonG.M., HoriO., ZoukourianC.Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.Proc Natl Acad Sci U S A1994; 91: 7742–6.
LiuB.F., MiyataS., HirotaY., HigoS., MiyazakiH., FukunagaM.Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cells.Kidney Int2003; 63: 947–57.
22.
SchmittC., von HeylD., RiegerS., ArbeiterK., BonzelK., FischbachM.Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content.Nephrol Dial Transplant2007; 22: 2038–44.
23.
WautierJ.L., SchmidtA.M.Protein glycation: a firm link to endothelial cell dysfunction.Circ Res2004; 95: 233–8.
24.
ZhengZ., SederholmF., AnderstamB., QureshiA., WangT., SöderstenP.Acute effects of peritoneal dialysis solutions on appetite in non-uremic rats.Kidney Int2001; 60: 2392–8.
25.
ZhengZ., AnderstamB., QureshiA., HeimbürgerO., WangT., SöderstenP.Heat sterilization of peritoneal dialysis solutions influences ingestive behavior in non-uremic rats.Kidney Int2002; 62: 1447–53.
